Ireland· IE-PA-PA0126/019/001
Phenobarbital 15 mg Tablets
A phenobarbital product containing phenobarbital, registered in Ireland by Clonmel Healthcare Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Phenobarbital is registered in 15 of 19 countries.
Countries holding a registration under ATC N03AA02 (phenobarbital), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Phenobarbital · ATC N03AA02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of phenobarbital costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Phenobarbital · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- IT Italy$0.10
The record
At a glance
HPRA (Ireland)- Active substance
- Phenobarbital
- Manufacturer
- Clonmel Healthcare Ltd
- Country
- Ireland (IE)
- ATC code
- N03AA02
- ATC class
- Phenobarbital
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0126/019/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
433 interactions on record for phenobarbital.
Graded by severity as the source publishes them — 133 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Phenobarbital · interactions on record
433 records
- 133 severe
- 236 moderate
- 19 minor
Most severe, free to view
- RolapitantA04AD14severe
- NaloxegolA06AH03severe
- NaldemedineA06AH05severe
- EliglustatA16AX10severe
45 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Phenobarbital in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesPhenobarbitalWINDER LABORATORIES, LLC
- United KingdomPhenobarbital 15mg tabletsMawdsley-Brooks & Company Ltd
- SwitzerlandAphenylbarbit 15 mg, TablettenStreuli Pharma AG
- CanadaPHENOBARBPENDOPHARM DIVISION OF PHARMASCIENCE INC
- NorwayFenemal NAFKragerø Tablettproduksjon AS
- PolandLuminalum UniaZakłady Farmaceutyczne "UNIA" Spółdzielnia Pracy
- FinlandBarbilettaeOrion Corporation Orion Pharma
- CzechiaPHENAEMALETTENDesitin Arzneimittel GmbH, Hamburg
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Belgium · Gardenal, Phenobarbital Sodium Sterop
- Bulgaria · Фенобарбитал Софарма
- Czechia · Luminal, Phenaemal
- Germany · Luminal, Luminaletten
- Denmark · Fenemal
- Estonia · Phenaemal
- Spain · Luminal, Luminaletas
- France · Gardenal
- United Kingdom (Northern Ireland) · Phenobarbital Accord, Phenobarbital Activase
- Greece · Gardenal
- Croatia · Phenobarbiton
- Hungary · Sevenal, Sevenaletta
- Italy · Fenobarbitale Sodico S.A.L.F, Gardenale
- Luxembourg · Gardenal
- Netherlands · Fenobarbital Teva
- Norway · Fenemal
- Poland · Luminalum, Luminalum Unia
- Portugal · Bialminal, Fenobarbital Labesfal
- Romania · Fenobarbital Arena, Fenobarbital Zentiva
- Slovakia · Luminal, Phenaemal 0,1
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/15c2069c-ec98-45b7-9791-af276d49830e GET /v1/drugs/15c2069c-ec98-45b7-9791-af276d49830e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N03AA",
"N03AA02"
],
"strength": null,
"pa_number": "PA0126/019/001",
"substances": [
"Phenobarbital"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "01/04/1977",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about phenobarbital.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.